Stock listing

Eupraxia Pharmaceuticals, Inc. (EPRX) Stock Price, News, Filings & Events

Selected listing: EPRX · NEO · CAD · CA

This page tracks Eupraxia Pharmaceuticals, Inc.'s EPRX:NEO listing on NEO in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following EPRX:NEO. EPRX:NEO is the selected stock listing for investors researching Eupraxia Pharmaceuticals, Inc.; the company-level investor brief is shared across the issuer while this page keeps ticker, exchange, currency, and canonical URL signals specific to EPRX:NEO. Eupraxia Pharmaceuticals, Inc. is a public company listed on the Canadian market under the ticker EPRX. The company has a market capitalization of approximately CAD 423. 7 million. Eupraxia focuses on developing innovative therapies to address unmet medical needs.

websiteEPRX:NEOCADCASEO content: aiUpdated June 24, 2026/stock/neo-eprx/eupraxia-pharmaceuticals-inc/l-ydf7qj8idr
Eupraxia Pharmaceuticals, Inc. logo
Ticker
EPRX:NEO
Asset type
Stock
Market cap
$423.7M
Sector
Health Technology
Industry
Biotechnology
Exchange
NEO
Currency
CAD

Eupraxia Pharmaceuticals, Inc. EPRX:NEO stock context

This page tracks Eupraxia Pharmaceuticals, Inc.'s EPRX:NEO listing on NEO in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following EPRX:NEO. EPRX:NEO is the selected stock listing for investors researching Eupraxia Pharmaceuticals, Inc.; the company-level investor brief is shared across the issuer while this page keeps ticker, exchange, currency, and canonical URL signals specific to EPRX:NEO. Eupraxia Pharmaceuticals, Inc. is a public company listed on the Canadian market under the ticker EPRX. The company has a market capitalization of approximately CAD 423. 7 million. Eupraxia focuses on developing innovative therapies to address unmet medical needs.

Research Eupraxia Pharmaceuticals, Inc.

Alternate listings